Titre : Tumeurs trophoblastiques

Tumeurs trophoblastiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Motor Vehicles
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs trophoblastiques : Questions médicales les plus fréquentes", "headline": "Tumeurs trophoblastiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs trophoblastiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-12", "dateModified": "2025-03-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs trophoblastiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Complications tumorales de la grossesse", "url": "https://questionsmedicales.fr/mesh/D011252", "about": { "@type": "MedicalCondition", "name": "Complications tumorales de la grossesse", "code": { "@type": "MedicalCode", "code": "D011252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.050.703.720" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Choriocarcinome", "alternateName": "Choriocarcinoma", "url": "https://questionsmedicales.fr/mesh/D002822", "about": { "@type": "MedicalCondition", "name": "Choriocarcinome", "code": { "@type": "MedicalCode", "code": "D002822", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.050.703.720.949.208" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Choriocarcinome non gestationnel", "alternateName": "Choriocarcinoma, Non-gestational", "url": "https://questionsmedicales.fr/mesh/D031954", "about": { "@type": "MedicalCondition", "name": "Choriocarcinome non gestationnel", "code": { "@type": "MedicalCode", "code": "D031954", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.050.703.720.949.208.438" } } }, { "@type": "MedicalWebPage", "name": "Tumeur trophoblastique du site d'implantation placentaire", "alternateName": "Trophoblastic Tumor, Placental Site", "url": "https://questionsmedicales.fr/mesh/D018245", "about": { "@type": "MedicalCondition", "name": "Tumeur trophoblastique du site d'implantation placentaire", "code": { "@type": "MedicalCode", "code": "D018245", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.050.703.720.949.208.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Maladie trophoblastique gestationnelle", "alternateName": "Gestational Trophoblastic Disease", "url": "https://questionsmedicales.fr/mesh/D031901", "about": { "@type": "MedicalCondition", "name": "Maladie trophoblastique gestationnelle", "code": { "@type": "MedicalCode", "code": "D031901", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.050.703.720.949.416" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Môle hydatiforme", "alternateName": "Hydatidiform Mole", "url": "https://questionsmedicales.fr/mesh/D006828", "about": { "@type": "MedicalCondition", "name": "Môle hydatiforme", "code": { "@type": "MedicalCode", "code": "D006828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.050.703.720.949.416.875" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Môle invasive", "alternateName": "Hydatidiform Mole, Invasive", "url": "https://questionsmedicales.fr/mesh/D002820", "about": { "@type": "MedicalCondition", "name": "Môle invasive", "code": { "@type": "MedicalCode", "code": "D002820", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.050.703.720.949.416.875.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Môle invasive", "alternateName": "Hydatidiform Mole, Invasive", "url": "https://questionsmedicales.fr/mesh/D002820", "about": { "@type": "MedicalCondition", "name": "Môle invasive", "code": { "@type": "MedicalCode", "code": "D002820", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.050.703.720.949.416.875.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Tumeurs trophoblastiques", "alternateName": "Trophoblastic Neoplasms", "code": { "@type": "MedicalCode", "code": "D014328", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Maryam Shahi", "url": "https://questionsmedicales.fr/author/Maryam%20Shahi", "affiliation": { "@type": "Organization", "name": "Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA. Shahi.Maryam@mayo.edu." } }, { "@type": "Person", "name": "Wendy Allen-Rhoades", "url": "https://questionsmedicales.fr/author/Wendy%20Allen-Rhoades", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Mayo Clinic, Rochester, MN, USA." } }, { "@type": "Person", "name": "Michael B Ishitani", "url": "https://questionsmedicales.fr/author/Michael%20B%20Ishitani", "affiliation": { "@type": "Organization", "name": "Department of Pediatric Surgery, Mayo Clinic, Rochester, MN, USA." } }, { "@type": "Person", "name": "Kevin M Elias", "url": "https://questionsmedicales.fr/author/Kevin%20M%20Elias", "affiliation": { "@type": "Organization", "name": "Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Dana-Farber Cancer Institute, MA, USA." } }, { "@type": "Person", "name": "Ross S Berkowitz", "url": "https://questionsmedicales.fr/author/Ross%20S%20Berkowitz", "affiliation": { "@type": "Organization", "name": "Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Dana-Farber Cancer Institute, MA, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Comparison of motor-vehicle involved e-scooter fatalities with other traffic fatalities.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36868674", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jsr.2022.10.008" } }, { "@type": "ScholarlyArticle", "name": "Haboob Dust Storms and Motor Vehicle Collision-related Trauma in Phoenix, Arizona.", "datePublished": "2023-07-17", "url": "https://questionsmedicales.fr/article/37527375", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5811/westjem.59381" } }, { "@type": "ScholarlyArticle", "name": "Electromagnetic Exposure Levels of Electric Vehicle Drive Motors to Passenger Wearing Cardiac Pacemakers.", "datePublished": "2024-07-06", "url": "https://questionsmedicales.fr/article/39001174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s24134395" } }, { "@type": "ScholarlyArticle", "name": "Blame attribution analysis of police motor vehicle collision reports involving child bicyclists.", "datePublished": "2023-06-09", "url": "https://questionsmedicales.fr/article/37295929", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/ip-2023-044884" } }, { "@type": "ScholarlyArticle", "name": "Drowsy driving and teen motor vehicle crashes: Impact of changing school start times.", "datePublished": "2022-06-02", "url": "https://questionsmedicales.fr/article/35652816", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jad.12053" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies urogénitales", "item": "https://questionsmedicales.fr/mesh/D000091642" }, { "@type": "ListItem", "position": 3, "name": "Maladies de l'appareil urogénital féminin et complications de la grossesse", "item": "https://questionsmedicales.fr/mesh/D005261" }, { "@type": "ListItem", "position": 4, "name": "Complications de la grossesse", "item": "https://questionsmedicales.fr/mesh/D011248" }, { "@type": "ListItem", "position": 5, "name": "Complications tumorales de la grossesse", "item": "https://questionsmedicales.fr/mesh/D011252" }, { "@type": "ListItem", "position": 6, "name": "Tumeurs trophoblastiques", "item": "https://questionsmedicales.fr/mesh/D014328" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs trophoblastiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs trophoblastiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs trophoblastiques", "description": "Comment diagnostique-t-on une tumeur trophoblastique ?\nQuels marqueurs tumoraux sont utilisés ?\nLes échographies sont-elles utiles ?\nQuand faut-il suspecter une tumeur trophoblastique ?\nPeut-on utiliser l'IRM pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Motor+Vehicles&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs trophoblastiques", "description": "Quels sont les symptômes courants ?\nLes tumeurs trophoblastiques causent-elles des douleurs ?\nY a-t-il des symptômes systémiques ?\nLes nausées sont-elles fréquentes ?\nPeut-on avoir des symptômes sans grossesse récente ?", "url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Motor+Vehicles&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs trophoblastiques", "description": "Peut-on prévenir les tumeurs trophoblastiques ?\nLe suivi après une grossesse est-il important ?\nLes antécédents familiaux influencent-ils le risque ?\nLes femmes ayant eu des grossesses multiples sont-elles à risque ?\nY a-t-il des recommandations pour les femmes enceintes ?", "url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Motor+Vehicles&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs trophoblastiques", "description": "Quels traitements sont disponibles ?\nLa chimiothérapie est-elle efficace ?\nQuand la chirurgie est-elle nécessaire ?\nY a-t-il des effets secondaires des traitements ?\nLa radiothérapie est-elle utilisée ?", "url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Motor+Vehicles&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs trophoblastiques", "description": "Quelles complications peuvent survenir ?\nLes tumeurs trophoblastiques peuvent-elles être mortelles ?\nComment les métastases se manifestent-elles ?\nLes complications affectent-elles la fertilité ?\nY a-t-il des risques psychologiques associés ?", "url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Motor+Vehicles&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs trophoblastiques", "description": "Quels sont les principaux facteurs de risque ?\nL'âge joue-t-il un rôle ?\nLes antécédents médicaux influencent-ils le risque ?\nLes habitudes de vie affectent-elles le risque ?\nLes facteurs environnementaux sont-ils impliqués ?", "url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Motor+Vehicles&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une tumeur trophoblastique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, échographies et biopsies." } }, { "@type": "Question", "name": "Quels marqueurs tumoraux sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de l'hormone chorionique gonadotrope (hCG) sont souvent mesurés." } }, { "@type": "Question", "name": "Les échographies sont-elles utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de visualiser les masses et d'évaluer leur taille." } }, { "@type": "Question", "name": "Quand faut-il suspecter une tumeur trophoblastique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Après une grossesse, si des symptômes anormaux ou des niveaux d'hCG élevés persistent." } }, { "@type": "Question", "name": "Peut-on utiliser l'IRM pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM peut être utilisée pour évaluer l'extension des tumeurs dans certains cas." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des saignements vaginaux, douleurs abdominales et nausées." } }, { "@type": "Question", "name": "Les tumeurs trophoblastiques causent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs abdominales peuvent survenir en raison de la pression exercée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, la fièvre et la perte de poids peuvent apparaître." } }, { "@type": "Question", "name": "Les nausées sont-elles fréquentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les nausées peuvent être fréquentes, surtout en cas de tumeur avancée." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans grossesse récente ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent apparaître même sans grossesse récente, nécessitant une évaluation." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs trophoblastiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical est conseillé." } }, { "@type": "Question", "name": "Le suivi après une grossesse est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier peut aider à détecter précocement des anomalies." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de tumeurs trophoblastiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les femmes ayant eu des grossesses multiples sont-elles à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les grossesses multiples peuvent augmenter le risque de tumeurs trophoblastiques." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les femmes enceintes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi prénatal régulier est recommandé pour surveiller la santé maternelle et fœtale." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la surveillance." } }, { "@type": "Question", "name": "La chimiothérapie est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chimiothérapie est souvent efficace pour traiter les tumeurs trophoblastiques." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle nécessaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est nécessaire si la tumeur est localisée et accessible." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme la fatigue, les nausées et la perte de cheveux peuvent survenir." } }, { "@type": "Question", "name": "La radiothérapie est-elle utilisée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La radiothérapie est rarement utilisée, sauf dans des cas spécifiques de métastases." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des saignements, des infections et des métastases." } }, { "@type": "Question", "name": "Les tumeurs trophoblastiques peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, si elles ne sont pas traitées, elles peuvent entraîner des complications graves." } }, { "@type": "Question", "name": "Comment les métastases se manifestent-elles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les métastases peuvent affecter les poumons, le foie et d'autres organes, causant divers symptômes." } }, { "@type": "Question", "name": "Les complications affectent-elles la fertilité ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent affecter la fertilité future des femmes." } }, { "@type": "Question", "name": "Y a-t-il des risques psychologiques associés ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diagnostic et le traitement peuvent entraîner des troubles psychologiques chez les patientes." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de grossesse molaires, les grossesses multiples et l'âge maternel avancé." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes de plus de 35 ans ont un risque accru de développer des tumeurs trophoblastiques." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de tumeurs trophoblastiques augmentent le risque de récidive." } }, { "@type": "Question", "name": "Les habitudes de vie affectent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines habitudes, comme le tabagisme, peuvent influencer le risque de complications." } }, { "@type": "Question", "name": "Les facteurs environnementaux sont-ils impliqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux peuvent également jouer un rôle dans le développement de ces tumeurs." } } ] } ] }

Sources (10000 au total)

Comparison of motor-vehicle involved e-scooter fatalities with other traffic fatalities.

Shared e-scooters are an emerging mode of transportation with many features that make their physical properties, behavior, and travel patterns unique. Safety concerns have been raised concerning their... Using media and police reports, a crash dataset was developed of rented dockless e-scooter fatalities in crashes involving motor vehicles that occurred in the United States in 2018-2019 (n = 17) and t... Compared to fatalities from other modes of transportation, e-scooter fatality victims are younger and more likely male. More e-scooter fatalities occur at night than any other mode, except pedestrians... E-scooter users share a mix of the same vulnerabilities as both pedestrians and cyclists. Although e-scooter fatalities are demographically most similar to motorcycle fatalities, crash circumstances s... E-scooter use must be understood by users and policymakers to be a distinct mode of transportation. This research highlights the similarities and differences between similar modes, like walking and cy...

Haboob Dust Storms and Motor Vehicle Collision-related Trauma in Phoenix, Arizona.

The Sonoran Desert region, encompassing most of southern Arizona, has an extreme climate that is famous for dust storms known as haboobs. These storms lead to decreased visibility and potentially haza... This study is a retrospective analysis of MVC-related trauma presentations to Phoenix, AZ, hospitals before and following haboob dust storms. These events were identified from 2009-2017 primarily usin... There were 31,133 MVC-related trauma encounters included from 2009-2017 and 111 haboob events meeting meteorological criteria during that period. There was a 17% decrease in MVC-related ED encounters ... Haboob dust storms in Phoenix, Arizona, are associated with a decrease in MVC-related injuries during the six-hour period following storm onset, likely indicating the success of public safety messagin...

Blame attribution analysis of police motor vehicle collision reports involving child bicyclists.

Injuries resulting from collisions between a bicyclist and driver are preventable and have high economic, personal and societal costs. Studying the language choices used by police officers to describe... A document analysis approach was used to analyse Alberta Transportation police collision reports from Calgary and Edmonton (2016-2017). Collision reports were categorised by the research team accordin... Of 171 police collision reports included, child bicyclists were perceived to be at fault in 78 reports (45.6%) and adult drivers were perceived at fault in 85 reports (49.7%). Child bicyclists were po... This work provides an opportunity to re-examine perceptions of factors related to motor vehicle and child bicyclist collisions with a view to prevention....

Drowsy driving and teen motor vehicle crashes: Impact of changing school start times.

Motor vehicle crashes (MVC) are the second leading cause of death for adolescents in the United States, with drowsy driving a major contributing factor. Early school start times have been identified a... Secondary school students (10th and 11th grade, 51.7% female, 67.8% White) in the United States completed annual surveys 1 year before and 2 years after implementation of later school start times (70-... With later start times, there was a significant drop in the percent of students who reported frequent drowsy driving (pre-change: 32.6%, post-change: 21.9%, follow-up: 22.8%). Weekday teen MVC rates w... Healthy school start times are important for adolescent health and safety, with study findings highlighting the downstream effects of increased sleep duration following a 70-min delay in secondary sch...

Ocular injuries associated with motor vehicle accidents: long term effects on quality of life.

To describe the prevalence and outcome of motor vehicle accidents-associated ocular injuries.... A survey of patients who presented to the emergency room at a level 1 trauma center with motor vehicle accidents-associated ocular injuries. A patient questionnaire and review of clinical notes were c... Of 274 motor vehicle accident victims with ocular injuries who presented to the emergency room, 40 (15%) responded to the survey. Over half of them were driving a vehicle, and most reported wearing a ... Our study sheds light on the details and extent of ocular involvement and the visual ability to perform daily activities following motor vehicle accidents....

Biopsychosocial sequelae and recovery trajectories from whiplash injury following a motor vehicle collision.

Five out of 10 injured in a motor vehicle collision (MVC) will develop persistent pain and disability. It is unclear if prolonged symptoms are related to peritraumatic pain/disability, psychological d... To test if widespread muscle fat infiltration (MFI) was (1) unique to those with poor recovery, (2) present in the peritraumatic stage, (3) related to known risk factors.... A cohort study, single-center academic hospital.... A total of 97 men and women (age 18-65) presenting to an urban academic emergency medicine department following MVC, but not requiring inpatient hospitalization.... Neck disability at 12-months.... Participants underwent magnetic resonance imaging (MRI) to quantify neck and lower extremity MFI, completed questionnaires on pain/disability and psychological distress (< 1-week, 2-weeks, 3-, and 12-... Significant differences for neck MFI were revealed, with the Recovered group having significantly lower neck MFI than the Mild and Moderate/Severe groups at all time points. The Mild group had signifi... Higher neck MFI and distress may represent a risk factor though it is unclear whether this is a pre-existing phenotype or result of the trauma.... ClinicalTrials.gov Identifier: NCT02157038....

Risk of motor vehicle collisions after methadone use: A systematic review and meta-analysis.

Methadone maintenance therapy is a leading treatment strategy for stabilizing and rehabilitating patients with opioid dependence; however, findings related to the risk of motor vehicle collisions afte... We completed a systematic review and meta-analysis of studies identified on six databases. Two reviewers independently screened the identified epidemiological studies, extracted data, and used the New... Among 1446 identified relevant studies, a total of 7 epidemiological studies enrolling 33226142 participants met the inclusion criteria. Overall, study participants with methadone use had a higher ris... The present review revealed that methadone use is significantly associated with a nearly doubled risk of motor vehicle collisions. Therefore, clinicians should exercise caution in implementing methado...

Psychiatric symptoms and pain in maxillofacial injury following motor vehicle accidents: A comparative study.

Post-traumatic stress disorders, depression, and pain are rarely discussed in the literature on maxillofacial injuries, and psychiatric symptoms and pain are not identified and managed in such patient... In this cross-sectional study, people injured in motor vehicle accidents from March to September 2015 who were referred to a medical educational center in the northern part of Iran for treatment follo... Maxillofacial injured patients had significant differences in terms of post-traumatic stress disorder (p = .006), depression (p = .001), pain (p = .001), and length of hospital stay (p = .002) than pa... Motor vehicle accident victims with maxillofacial injuries suffered significantly more from post-traumatic stress disorders and depression, pain and length of hospital stay than patients with other in...

Evaluation of mechanism of injury criteria for field triage of occupants involved in motor vehicle collisions.

The mechanism of injury (MOI) criteria assist in determining which patients are at high risk of severe injury and would benefit from direct transport to a trauma center. The goal of this study was to ... Data were obtained from NASS and Crash Investigation Sampling System (CISS) for 2000-2009 and 2010-2019. Cases missing injury severity were excluded, and all other missing data were imputed. The outco... There were 150,683 (weighted 73,423,189) cases identified for analysis. There was a small but statistically significant improvement in the AUROC of the MOI criteria in the later decade (2010-2019; AUR... The MOI criteria for MVCs in the current CDC guidelines still perform well even as vehicle design has changed. However, the sensitivity of these criteria for older adults is much lower than for younge...